ER+/HER2+ Metastatic Breast Cancer

1 Views
administrator
administrator
07/03/23

Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next